Theseus Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch THRX and buy or sell other stocks, ETFs, and their options commission-free!

About THRX

Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies.

CEO

Timothy Clarkson

CEOTimothy Clarkson

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2017

Founded2017

Employees

—

Employees—

THRX Key Statistics

Market cap

177.04M

Market cap177.04M

Price-Earnings ratio

-3.02

Price-Earnings ratio-3.02

Dividend yield

—

Dividend yield—

Average volume

372.69K

Average volume372.69K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$12.37

52 Week high$12.37

52 Week low

$2.05

52 Week low$2.05

People also own

Based on the portfolios of people who own THRX. This list is generated using Robinhood data, and it’s not a recommendation.